{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:35:01Z","timestamp":1774467301521,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3021,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.exphem.2013.11.006","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T11:52:51Z","timestamp":1385034771000},"page":"183-191.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Single-cell analysis of K562 cells: An imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein"],"prefix":"10.1016","volume":"42","author":[{"given":"Ehsan Ghayoor","family":"Karimiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Marriage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita J.","family":"Merritt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Burthem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard John","family":"Byers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.R.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2013.11.006_bib1","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.11.006_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1432-0436.2008.00270.x","article-title":"Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia","volume":"76","author":"Simanovsky","year":"2008","journal-title":"Differentiation"},{"key":"10.1016\/j.exphem.2013.11.006_bib3","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1093\/nar\/gkn725","article-title":"High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA","volume":"36","author":"Mestdagh","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2013.11.006_bib4","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood.V99.8.2957","article-title":"The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr\/abl","volume":"99","author":"He","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.11.006_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer cell"},{"key":"10.1016\/j.exphem.2013.11.006_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/blood-2002-09-2896","article-title":"Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis","volume":"102","author":"Branford","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.11.006_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI118820","article-title":"Bcr\/Abl expression stimulates integrin function in hematopoietic cell lines","volume":"98","author":"Bazzoni","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2013.11.006_bib8","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/sj.leu.2402179","article-title":"Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR\/ABL inhibition, cytotoxic drugs, and gamma-irradiation","volume":"15","author":"Damiano","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.11.006_bib9","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1038\/sj.onc.1208796","article-title":"Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemia","volume":"24","author":"Barnes","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2013.11.006_bib10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/sj.leu.2401730","article-title":"Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7","volume":"14","author":"Issaad","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.11.006_bib11","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.V80.7.1788.1788","article-title":"Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr\/abl","volume":"80","author":"Laneuville","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.11.006_bib12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccr.2008.04.018","article-title":"Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression","volume":"13","author":"Bueno","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2013.11.006_bib13","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1038\/onc.2008.274","article-title":"MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death","volume":"27","author":"Schickel","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2013.11.006_bib14","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/jcbfm.2008.1","article-title":"Increase in circulating CD34-positive cells in patients with angiographic evidence of moyamoya-like vessels","volume":"28","author":"Yoshihara","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.exphem.2013.11.006_bib15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2013.11.006_bib16","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.1073\/pnas.0506216102","article-title":"MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation","volume":"102","author":"Felli","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2013.11.006_bib17","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.leukres.2009.04.039","article-title":"MicroRNAs in normal and malignant myelopoiesis","volume":"33","author":"Pelosi","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2013.11.006_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12079-011-0139-x","article-title":"MicroRNAs 130a\/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML","volume":"5","author":"Suresh","year":"2011","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.exphem.2013.11.006_bib19","doi-asserted-by":"crossref","unstructured":"Verma M, Karimiani EG, Byers RJ, Rehman S, Westerhoff HV, Day PJ. Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies. Integr Biol (Camb);5:543\u2013554.","DOI":"10.1039\/c3ib20230e"},{"key":"10.1016\/j.exphem.2013.11.006_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ccr.2008.05.013","article-title":"Linking miRNA regulation to BCR-ABL expression: the next dimension","volume":"13","author":"Faber","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2013.11.006_bib21","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.leukres.2011.03.029","article-title":"MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?","volume":"35","author":"Lopotova","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2013.11.006_bib22","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2013.11.006_bib23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2013.11.006_bib24","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2013.11.006_bib25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.leukres.2005.10.017","article-title":"MicroRNAs and leukemias: how strong is the connection?","volume":"30","author":"Calin","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2013.11.006_bib26","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1073\/pnas.0508889103","article-title":"microRNAs exhibit high frequency genomic alterations in human cancer","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2013.11.006_bib27","doi-asserted-by":"crossref","first-page":"15484","DOI":"10.1073\/pnas.0703037104","article-title":"MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells","volume":"104","author":"Greco","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2013.11.006_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bios.2013.01.019","article-title":"Rapid, quantitative, reverse transcription PCR in a polymer microfluidicchip","volume":"44C","author":"Curtis Saunders","year":"2013","journal-title":"Biosens Bioelectron"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X13008655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X13008655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:31:18Z","timestamp":1759566678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X13008655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0301472X13008655"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2013.11.006","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cell analysis of K562 cells: An imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2013.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}